FDA Week | Former FDA, HHS Staffers Praise New FDA Chief Counsel’s Experience

This week, President Trump released his FY 2026 discretionary budget proposal, which calls for large cuts to federal health agencies; and House Republicans continue negotiations over the policies that will be included in the budget reconciliation package.

This week, the House and Senate both agreed to a joint budget resolution, advancing to the next step of the reconciliation process, and CMS released its proposed rules for FY 2026 inpatient and post-acute care payments.

This week, HHS announced plans for an additional reduction in 10,000 full-time employees and consolidation of departmental divisions, and the nominees to head the FDA and the NIH were confirmed by the Senate.

This week, HHS and DEA postponed the effective date of their buprenorphine telemedicine prescribing rule until 2026 and HHS continued the Biden-era defense of its authority to dictate 340B rebate models.